SCHEMBL17348570

SCHEMBL17348570

CC1CCOCC12CCC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15927296 0.95 — —
SCHEMBL22813394 0.91 — —
SCHEMBL26519682 0.91 — —
SCHEMBL16659517 0.84 — —
SCHEMBL16659516 0.83 — —
SCHEMBL16659522 0.79 — —
SCHEMBL16659520 0.76 — —
SCHEMBL2786155 0.74 — —
SCHEMBL23083342 0.74 SLC6A2 (0.38) —
SCHEMBL23083352 0.74 SLC6A2 (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021154661-A1 1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS BRISTOL-MYERS SQUIBB COMPANY (US) 2021-08-05 — — WO disclosed
EP-3279187-B1 9-MEMBERED FUSED RING DERIVATIVE SHIONOGI & CO (JP) 2021-06-02 — — EP disclosed
US-20170107234-A1 TRICYCLIC HETEROCYCLE DERIVATIVES HAVING HIV REPLICATION INHIBITORY EFFECT SHIONOGI & CO., LTD. (JP) 2017-04-20 — — US disclosed
US-20150361093-A1 HIV REPLICATION INHIBITOR SHIONOGI & CO., LTD. (JP) 2015-12-17 — — US disclosed
Send feedback